secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2026-04-14T23:59:59+00:00
Accession:  0001606498-26-000046
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical to be acquired by AIP for $25/share, $1.272B enterprise value
----------------------------------------------------------------------------

- Avanos stockholders receive $25.00 per share in cash; enterprise value approx. $1.272B.
- Premium of 72.1% to April 13 closing price and 82.8% to 30-day VWAP.
- Acquisition unanimously approved by Avanos Board; expected to close H2 2026.
- Closing conditions include stockholder approval and HSR clearance; no financing condition.
- Avanos common stock will be delisted from NYSE; 2026 annual meeting postponed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000046/0001606498-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000046/avns-20260413.htm
  HTML page:      https://secwatch.observer/filing/0001606498-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer